Protagonist Therapeutics, Inc reports

Company location: Newark, CA
Fiscal year end: 31 December

Protagonist Therapeutics, Inc has filed 682 SEC EDGAR filings since 28 Sep 2006

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 576-600 of 681 matching filings.

Per page

25

Current page

24

424B5 File 333-220314

424B5

Filing date: 13 Oct 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-220314

424B5

Filing date: 11 Oct 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 10 Oct 2017
Reporting date: 05 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-220314

EFFECT filing

Filing date: 05 Oct 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 03 Oct 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 27 Sep 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 21 Sep 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Sep 2017
Reporting date: 12 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-220314

S-3

Filing date: 01 Sep 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 001-37852

CT ORDER filing

Filing date: 01 Sep 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Aug 2017
Reporting date: 29 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 29 Aug 2017
Reporting date: 28 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-37852

10-Q

Filing date: 08 Aug 2017
Reporting date: 30 Jun 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37852

8-K

Filing date: 08 Aug 2017
Reporting date: 08 Aug 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 001-37852

8-K/A

Filing date: 31 Jul 2017
Reporting date: 26 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 12 Jul 2017
Reporting date: 10 Jul 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 15 Jun 2017
Reporting date: 15 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 08 Jun 2017
Reporting date: 07 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37852

FORM 8-K

Filing date: 08 Jun 2017
Reporting date: 07 Jun 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PROTAGONIST THERAPEUTICS, INC.

Filing date: 01 Jun 2017
Reporting date: 30 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89601

PROTAGONIST THERAPEUTICS, INC

Filing date: 01 Jun 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37852

FORM 8-K

Filing date: 30 May 2017
Reporting date: 26 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 26 May 2017
Reporting date: 25 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 26 May 2017
Reporting date: 25 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 26 May 2017
Reporting date: 25 May 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .